These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1549345)

  • 1. Melittin resistance: a counterselection for ras transformation.
    Sharma SV
    Oncogene; 1992 Feb; 7(2):193-201. PubMed ID: 1549345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melittin-induced hyperactivation of phospholipase A2 activity and calcium influx in ras-transformed cells.
    Sharma SV
    Oncogene; 1993 Apr; 8(4):939-47. PubMed ID: 8455945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of bee venom phospholipase A2 contamination in melittin fractions to presumed activation of tissue phospholipase A2.
    Fletcher JE; Michaux K; Jiang MS
    Toxicon; 1990; 28(6):647-56. PubMed ID: 2402761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melittin binds to secretory phospholipase A2 and inhibits its enzymatic activity.
    Saini SS; Peterson JW; Chopra AK
    Biochem Biophys Res Commun; 1997 Sep; 238(2):436-42. PubMed ID: 9299527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responses of purified phospholipases A2 to phospholipase A2 activating protein (PLAP) and melittin.
    Steiner MR; Bomalaski JS; Clark MA
    Biochim Biophys Acta; 1993 Feb; 1166(1):124-30. PubMed ID: 8431486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melittin and phospholipase A2 from bee (Apis mellifera) venom cause necrosis of murine skeletal muscle in vivo.
    Ownby CL; Powell JR; Jiang MS; Fletcher JE
    Toxicon; 1997 Jan; 35(1):67-80. PubMed ID: 9028010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipid dependence of membrane-bound phospholipase A2 in ras-transformed NIH 3T3 fibroblasts.
    Momchilova A; Markovska T; Pankov R
    Biochimie; 1998 Dec; 80(12):1055-62. PubMed ID: 9924985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsomal phospholipase A2 is activated by surfactant toxins in 3T3 mouse fibroblasts.
    Kawaguchi H; Shier TW
    Toxicol Lett; 1987 Feb; 35(2-3):261-8. PubMed ID: 3824415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of bee venom phospholipase A2 through a peptide-enzyme complex.
    Mingarro I; Pérez-Payá E; Pinilla C; Appel JR; Houghten RA; Blondelle SE
    FEBS Lett; 1995 Sep; 372(1):131-4. PubMed ID: 7556634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholipase A2-activating protein induces the synthesis of IL-1 and TNF in human monocytes.
    Bomalaski JS; Ford T; Hudson AP; Clark MA
    J Immunol; 1995 Apr; 154(8):4027-31. PubMed ID: 7706741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ras-p21 activates phospholipase D and A2, but not phospholipase C or PKC, in Xenopus laevis oocytes.
    Carnero A; Dolfi F; Lacal JC
    J Cell Biochem; 1994 Apr; 54(4):478-86. PubMed ID: 8014197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of anterior pituitary prolactin release by melittin, an activator of phospholipase A2.
    Grandison L
    Endocrinology; 1984 Jan; 114(1):1-7. PubMed ID: 6418521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation by the k-ras oncogene correlates with increases in phospholipase A2 activity, glycerophosphoinositol production and phosphoinositide synthesis in thyroid cells.
    Valitutti S; Cucchi P; Colletta G; Di Filippo C; Corda D
    Cell Signal; 1991; 3(4):321-32. PubMed ID: 1657098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipases A2 in ras-transformed and immortalized human mammary epithelial cells.
    Guthridge CJ; Stampfer MR; Clark MA; Steiner MR
    Cancer Lett; 1994 Oct; 86(1):11-21. PubMed ID: 7954346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. trans-Dominant suppressor mutations of the H-ras oncogene.
    Ogiso Y; Gutierrez L; Wrathall LS; Lu YY; Blair DG; Clanton DJ; Hwang YW; Shih TY
    Cell Growth Differ; 1990 May; 1(5):217-24. PubMed ID: 2150753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformation of NIH/3T3 to anchorage independence by H-ras is accompanied by loss of suppressor activity.
    Tolsma SS; Cohen JD; Ehrlich LS; Bouck NP
    Exp Cell Res; 1993 Apr; 205(2):232-9. PubMed ID: 8482334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to apoptosis induced by alkylating agents in v-Ha-ras-transformed cells due to defect in p53 function.
    Kuo ML; Chou YW; Chau YP; Huang TS
    Mol Carcinog; 1997 Apr; 18(4):221-31. PubMed ID: 9142217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCH 51344 inhibits ras transformation by a novel mechanism.
    Kumar CC; Prorock-Rogers C; Kelly J; Dong Z; Lin JJ; Armstrong L; Kung HF; Weber MJ; Afonso A
    Cancer Res; 1995 Nov; 55(21):5106-17. PubMed ID: 7585559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of transforming ras proteins containing leucine at position 61 by a new mouse monoclonal antibody, ras(53-69)Leu61.
    Bizub D; Fischberg-Bender E; Heimer EP; Felix A; Skalka AM
    Cancer Res; 1989 Nov; 49(22):6425-31. PubMed ID: 2680065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a human MSX-2 cDNA and its fragment isolated as a transformation suppressor gene against v-Ki-ras oncogene.
    Takahashi C; Akiyama N; Matsuzaki T; Takai S; Kitayama H; Noda M
    Oncogene; 1996 May; 12(10):2137-46. PubMed ID: 8668339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.